✨ Free AI Report
The Oncology Institute, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research The Oncology Institute, Inc.
Company Research

The Oncology Institute, Inc.: Business Overview, Financials & Competitive Analysis

The Oncology Institute (NASDAQ: TOI), founded in 2007, is advancing oncology by delivering highly specialized, value-based cancer care in the community setting, offering cutting-edge, evidence-based cancer care to a p...

Analyst-debate audio for The Oncology Institute, Inc.

AskCyborg analysts argue the bull and bear cases for The Oncology Institute, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

TOI is well-positioned in the value-based oncology market with potential for margin expansion through scale and asset-light...

Read the full analyst-debate transcript →
Industry Healthcare Services - Specialty Oncology / Value-Based Cancer Care
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest The Oncology Institute, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

The Oncology Institute, Inc. Overview

Pro stress-test →

The Oncology Institute (NASDAQ: TOI), founded in 2007, is advancing oncology by delivering highly specialized, value-based cancer care in the community setting, offering cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is transforming community-based oncology delivery.

Strategic Profile

Pro stress-test →

TOI is positioned for growth through 2028 with a target of ~20% annual revenue growth, driven by the migration toward comprehensive oncology care in a value-based landscape. 2026 is expected to represent TOI's first full year of Adjusted EBITDA profitability as a public company.

Competitive Landscape

Pro stress-test →

TOI is one of the largest value-based oncology groups in the United States. The company competes in the community-based oncology market with a focus on value-based contracting, capitation, and integrated care delivery. Competitors include larger healthcare systems and specialized oncology networks transitioning to value-based models.

Industry Context

The Oncology Institute, Inc. operates in Healthcare Services - Specialty Oncology / Value-Based Cancer Care.

Key facts

Founded: 2007 · Headquarters: Cerritos, US · Employees: 180+ clinicians + support staff · Revenue: $630-650M (2026 guidance) · Market cap: $356M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on The Oncology Institute, Inc..

  • 2026 revenue guidance of $630-650M represents 28% YoY growth, with ~$150M from capitation revenue.
  • TOI deployed a near-touchless prior authorization workflow with >80% reduction in office-visit authorization submission time, freeing hundreds of staff hours weekly.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Board appointment of Kim Tzoumakas, CEO of VytlOne National Pharmacy Services with oncology/pharmacy expertise
  • January 2026Leadership promotions: Rakesh Panda to CIO and Nolan Mariano to Chief People Officer
  • +2 moreTrack every material event for The Oncology Institute, Inc. as it happens. Explore monitoring →
Get alerted when The Oncology Institute, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare The Oncology Institute, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

The Oncology Institute, Inc. operates in Healthcare Services - Specialty Oncology / Value-Based Cancer Care. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Services - Specialty Oncology / Value-Based Cancer Care research →
NEW · MCP server

Ask your AI assistant about The Oncology Institute, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare The Oncology Institute, Inc. and its top competitor on Cyborg Score”
“What did The Oncology Institute, Inc. do this quarter?”
“Is The Oncology Institute, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does The Oncology Institute, Inc. do?+
The Oncology Institute (NASDAQ: TOI), founded in 2007, is advancing oncology by delivering highly specialized, value-based cancer care in the community setting, offering cutting-edge, evidence-based cancer care to a p...
What is The Oncology Institute, Inc.'s Cyborg Score?+
The Oncology Institute, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are The Oncology Institute, Inc.'s main competitors?+
Named competitors include Integrated Oncology Services, Value-Based Oncology Networks, Community Oncology Groups. The full competitive landscape is in the AskCyborg report.
How can I get the full The Oncology Institute, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the The Oncology Institute, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track The Oncology Institute, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual